PTX3 and glioblastoma: In GBM, downregulating the expression of ZNF148 could diminish PTX3 expression, consequently reducing the proliferation and migration of transformed DCs (t-DCs) and restraining the expression of costimulatory, thereby diminishing the tumor-promoting ability of t-DCs in vivo [55].